Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05154058 · ClinicalTrials.gov registry record · NA
Medial Peel Release Technique TKA Randomized Clinical Trial
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05154058 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 4 participants.
The verdict
NCT05154058, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Medial subperiosteal release is a commonly performed technique to improve surgical exposure and aid in joint balancing. This is a routine step during primary total knee arthroplasty that will be conducted on every enrolled patient. This is commonly performed both via scalpel (aka sharp medial peel) or electrocautery. The intervention will be randomly assigning subjects undergoing TKA into two groups, one receiving subperiosteal release using a scalpel (aka sharp medial peel) and the other via electrocautery.
Interventions
- PROCEDURE Medial Subperiosteal Release with Sharp Dissection
- PROCEDURE Medial Subperiosteal Release with Electrocautery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2022-11-02 |
| Est. Completion | 2023-01-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05154058
The ClinicalTrials.gov registry entry for NCT05154058 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medial Subperiosteal Release with Sharp Dissection is the first listed.
NCT05154058 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05154058 about?
NCT05154058 is a clinical study titled "Medial Peel Release Technique TKA Randomized Clinical Trial". Medial subperiosteal release is a commonly performed technique to improve surgical exposure and aid in joint balancing. This is a routine step during primary total knee arthroplasty that will be conducted on every enrolled patient. This is commonly performed both via scalpel (aka sharp medial peel) ...
What is the current status of trial NCT05154058?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2022-11-02. Estimated completion is 2023-01-18.
What interventions are being tested in trial NCT05154058?
The interventions under investigation include: Medial Subperiosteal Release with Sharp Dissection (PROCEDURE), Medial Subperiosteal Release with Electrocautery (PROCEDURE).
Who is sponsoring clinical trial NCT05154058?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.